{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:41:16Z","timestamp":1791423676668,"version":"4.3.3"},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"15","license":[{"start":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T00:00:00Z","timestamp":1638576000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>Cardiovascular disease is a common complication in acromegaly. We investigated the risk of cardiovascular disease and mortality in patients with acromegaly in a large-scale population using nationwide data in Korea.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>We performed a nationwide, retrospective, observational, cohort study of patients with acromegaly (n = 1874) and age- and sex-matched subjects without acromegaly (n = 9370) for a mean follow-up of 7.5 \u00b1 3.2 years. The study outcomes were myocardial infarction, stroke, atrial fibrillation, congestive heart failure, and all-cause death. All outcomes were analysed by Cox proportional hazards regression analysis while controlling for age, sex, household income, place, Type 2 diabetes, hypertension, and dyslipidaemia. The incidence (per 1000 person-years) of atrial fibrillation (3.06 vs. 1.70; P = 0.001), congestive heart failure (3.11 vs. 1.63; P &amp;lt; 0.001), and all-cause mortality (6.31 vs. 4.03; P &amp;lt; 0.001) in patients with acromegaly was higher than in controls. However, the incidence of myocardial infarction and stroke did not differ between groups. After adjustment for covariates, the risk for atrial fibrillation [hazard ratio (HR): 1.59; 95% confidence interval (CI): 1.09\u20132.31], congestive heart failure (HR: 1.54; 95% CI: 1.06\u20132.25), and all-cause mortality (HR: 1.31; 95% CI: 1.01\u20131.69) was significantly higher in patients with acromegaly. In time lag sensitivity analysis, a higher risk for atrial fibrillation was observed only in the first 4 years after diagnosis in acromegaly patients compared with controls (HR: 3.05; 95% CI: 1.94\u20134.79).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Patients with acromegaly were at higher risk for atrial fibrillation, congestive heart failure, and all-cause death. The risk of atrial fibrillation had a time-dependent association with acromegaly.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurheartj\/ehab822","type":"journal-article","created":{"date-parts":[[2021,11,18]],"date-time":"2021-11-18T12:08:31Z","timestamp":1637237311000},"page":"1491-1499","source":"Crossref","is-referenced-by-count":51,"title":["Acromegaly and cardiovascular outcomes: a cohort study"],"prefix":"10.1093","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8535-0565","authenticated-orcid":false,"given":"Sangmo","family":"Hong","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Guri Hospital, College of Medicine, Hanyang University , 153, Gyeongchun-ro, Guri-si, Gyeonggi-do 11923, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7738-2284","authenticated-orcid":false,"given":"Kyung-Soo","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, CHA Bundang Medical Center, CHA University School of Medicine , 59, Yatap-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 13496, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungdo","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Statistics and Actuarial Science, Soongsil University , 369, Sangdo-ro, Dongjak-gu, Seoul 06978, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9415-9965","authenticated-orcid":false,"given":"Cheol-Young","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine , 29, Saemunan-ro, Jongno-gu, Seoul 03181, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,4]]},"reference":[{"key":"2022102516570473400_ehab822-B1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1507\/endocrj.52.69","article-title":"Acute hyperglycemia and activation of the beta-adrenergic system do not exhibit synergistic inhibitory actions on thyrotropin-releasing hormone (TRH)-induced thyroid stimulating hormone (TSH) secretion","volume":"52","author":"Park","year":"2005","journal-title":"Endocr J"},{"key":"2022102516570473400_ehab822-B2","first-page":"2492","article-title":"Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients","volume":"82","author":"Yang","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102516570473400_ehab822-B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102516570473400_ehab822-B4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1530\/EJE-11-0408","article-title":"Determinants of cardiac disease in newly diagnosed patients with acromegaly: results of a 10 year survey study","volume":"165","author":"Colao","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B5","first-page":"H393","article-title":"Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice","volume":"275","author":"Tanaka","year":"1998","journal-title":"Am J Physiol"},{"key":"2022102516570473400_ehab822-B6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102516570473400_ehab822-B7","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1046\/j.1365-2265.2003.01780.x","article-title":"Growth hormone, acromegaly, and heart failure: an intricate triangulation","volume":"59","author":"Sacca","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022102516570473400_ehab822-B8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00024677-200403050-00004","article-title":"Cardiac abnormalities in acromegaly. Pathophysiology and implications for management","volume":"3","author":"Vitale","year":"2004","journal-title":"Treat Endocrinol"},{"key":"2022102516570473400_ehab822-B9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1365-2265.2001.01319.x","article-title":"Occurrence of ventricular late potentials in patients with active acromegaly","volume":"55","author":"Herrmann","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022102516570473400_ehab822-B10","first-page":"22","article-title":"The incidence of cerebrovascular accidents and second brain tumors in patients with pituitary adenoma: a population-based study","volume":"1","author":"Brown","year":"2014","journal-title":"Neurooncol Pract"},{"key":"2022102516570473400_ehab822-B11","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1530\/EJE-16-1064","article-title":"Changes in the management and comorbidities of acromegaly over three decades: the French Acromegaly Registry","volume":"176","author":"Maione","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B12","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/EJE-13-1022","article-title":"Could different treatment approaches in acromegaly influence life expectancy? A comparative study between Bulgaria and Campania (Italy)","volume":"171","author":"Colao","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B13","first-page":"e15","article-title":"Cohort profile: the National Health Insurance Service-National Sample Cohort (NHIS-NSC), South Korea","volume":"46","author":"Lee","year":"2017","journal-title":"Int J Epidemiol"},{"key":"2022102516570473400_ehab822-B14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4093\/dmj.2014.38.5.395","article-title":"Background and data configuration process of a nationwide population-based study using the Korean national health insurance system","volume":"38","author":"Song","year":"2014","journal-title":"Diabetes Metab J"},{"key":"2022102516570473400_ehab822-B15","author":"Welfare MoHa","year":"2021"},{"key":"2022102516570473400_ehab822-B16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-019-1032-6","article-title":"The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011-2015","volume":"14","author":"Lim","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"2022102516570473400_ehab822-B17","first-page":"531","article-title":"The occurrence of lung cancer in man","volume":"9","author":"Levin","year":"1953","journal-title":"Acta Unio Int Contra Cancrum"},{"key":"2022102516570473400_ehab822-B18","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-08-0267","article-title":"A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly","volume":"159","author":"Holdaway","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B19","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1172\/JCI39375","article-title":"Acromegaly pathogenesis and treatment","volume":"119","author":"Melmed","year":"2009","journal-title":"J Clin Invest"},{"key":"2022102516570473400_ehab822-B20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/ERC-16-0106","article-title":"Mortality in acromegaly: a 20-year follow-up study","volume":"23","author":"Ritvonen","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"2022102516570473400_ehab822-B21","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s11102-017-0827-5","article-title":"Incidence of myocardial infarction and stroke in acromegaly patients: results from the German Acromegaly Registry","volume":"20","author":"Schofl","year":"2017","journal-title":"Pituitary"},{"key":"2022102516570473400_ehab822-B22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-16-0562","article-title":"Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly","volume":"175","author":"Sardella","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B23","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/cen.13285","article-title":"Glucose and lipid levels with lanreotide autogel 120 mg in treatment-naive patients with acromegaly: data from the PRIMARYS study","volume":"86","author":"Caron","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2022102516570473400_ehab822-B24","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1210\/js.2017-00334","article-title":"Increased risk of persistent glucose disorders after control of acromegaly","volume":"1","author":"Rochette","year":"2017","journal-title":"J Endocr Soc"},{"key":"2022102516570473400_ehab822-B25","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"key":"2022102516570473400_ehab822-B26","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ecl.2019.08.008","article-title":"Hypertension and acromegaly","volume":"48","author":"Puglisi","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"2022102516570473400_ehab822-B27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1530\/EJE-18-0255","article-title":"Mortality in acromegaly decreased in the last decade: a systematic review and meta-analysis","volume":"179","author":"Bolfi","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"2022102516570473400_ehab822-B28","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.hfc.2019.03.001","article-title":"Acromegaly and heart failure","volume":"15","author":"Colao","year":"2019","journal-title":"Heart Fail Clin"},{"key":"2022102516570473400_ehab822-B29","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s11102-011-0318-z","article-title":"Improvement of cardiac parameters in patients with acromegaly treated with medical therapies","volume":"15","author":"Colao","year":"2012","journal-title":"Pituitary"},{"key":"2022102516570473400_ehab822-B30","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102516570473400_ehab822-B31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11102-007-0062-6","article-title":"The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly","volume":"11","author":"De Marinis","year":"2008","journal-title":"Pituitary"},{"key":"2022102516570473400_ehab822-B32","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/oxfordjournals.eurheartj.a060047","article-title":"Arrhythmia profile in acromegaly","volume":"13","author":"Kahaly","year":"1992","journal-title":"Eur Heart J"},{"key":"2022102516570473400_ehab822-B33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1007\/s11102-016-0749-7","article-title":"Low frequency of cardiac arrhythmias and lack of structural heart disease in medically-naive acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment","volume":"19","author":"Warszawski","year":"2016","journal-title":"Pituitary"},{"key":"2022102516570473400_ehab822-B34","doi-asserted-by":"crossref","first-page":"6935054","DOI":"10.1155\/2018\/6935054","article-title":"Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease","volume":"2018","author":"Popielarz-Grygalewicz","year":"2018","journal-title":"Int J Endocrinol"},{"key":"2022102516570473400_ehab822-B35","first-page":"475","article-title":"Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data","volume":"5","author":"Norberg","year":"2013","journal-title":"Clin Epidemiol"},{"key":"2022102516570473400_ehab822-B36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s12020-020-02206-7","article-title":"Acromegaly in the elderly patients","volume":"68","author":"Ambrosio","year":"2020","journal-title":"Endocrine"},{"key":"2022102516570473400_ehab822-B37","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijcard.2016.04.036","article-title":"Underweight is a risk factor for atrial fibrillation: a nationwide population-based study","volume":"215","author":"Kang","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022102516570473400_ehab822-B38","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ijcard.2016.08.296","article-title":"Evaluation of the association between diabetic retinopathy and the incidence of atrial fibrillation: a nationwide population-based study","volume":"223","author":"Lee","year":"2016","journal-title":"Int J Cardiol"},{"key":"2022102516570473400_ehab822-B39","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1093\/eurheartj\/ehx585","article-title":"Cholesterol variability and the risk of mortality, myocardial infarction, and stroke: a nationwide population-based study","volume":"38","author":"Kim","year":"2017","journal-title":"Eur Heart J"},{"key":"2022102516570473400_ehab822-B40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4093\/dmj.2016.40.1.79","article-title":"Data analytic process of a nationwide population-based study using National Health Information Database established by National Health Insurance Service","volume":"40","author":"Lee","year":"2016","journal-title":"Diabetes Metab J"},{"key":"2022102516570473400_ehab822-B41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.4070\/kcj.2020.0171","article-title":"Cardiovascular research using the Korean National Health Information Database","volume":"50","author":"Choi","year":"2020","journal-title":"Korean Circ J"},{"key":"2022102516570473400_ehab822-B42","doi-asserted-by":"crossref","first-page":"3231","DOI":"10.1210\/jc.2017-02774","article-title":"Association between diabetic retinopathy and Parkinson disease: the Korean National Health Insurance Service Database","volume":"103","author":"Lee","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"2022102516570473400_ehab822-B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/15\/1491\/46628761\/ehab822.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/43\/15\/1491\/46628761\/ehab822.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,25]],"date-time":"2022-10-25T18:07:59Z","timestamp":1666721279000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/43\/15\/1491\/6449457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,4]]},"references-count":43,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2021,12,4]]},"published-print":{"date-parts":[[2022,4,14]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehab822","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,4,14]]},"published":{"date-parts":[[2021,12,4]]}}}